Christopher Mitchell Littmann, PA

Christopher Littmann practices at Southern California Orthopedic Institute in Valencia, California.

Christopher Littmann's NPI, 1215330808, was assigned on September 26, 2014. Christopher Littmann holds California license 51950.

Christopher Littmann's primary practice is Southern California Orthopedic Institute, at 24051 Newhall Ranch Rd, Valencia, CA 91355 in Los Angeles County. The practice phone is (661) 254-6364.

Christopher Littmann's primary practice is Southern California Orthopedic Institute in Valencia, California. Christopher Littmann is also affiliated with Henry Mayo Newhall Hospital. The medical group on file is UCLA Health. Dmand AI also links Christopher Littmann to 1 more group practice or clinic, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Christopher Littmann practices, 2 sites in all. Vendor and product names are available with a free account.

Medical is Christopher Littmann's primary specialty in the NPI Registry, under taxonomy code 363AM0700X. Christopher Littmann is licensed in California.

Dmand AI lists arthritis, bursitis, carpal tunnel syndrome, enthesopathy in arms, fibromyalgia and chronic pain, hand joint or tendon inflammation, joint pain and lower back pain among the conditions Christopher Littmann treats.

CMS data shows 3,436 Medicare services from Christopher Littmann across 18 procedure codes in 2024, for 540 Medicare patients. Medicare paid $128,674 for them. Every service was in an office.

CMS counts 540 Medicare patients who saw Christopher Littmann in 2024. The largest group is 65 to 74, with 308 patients. 75% of them have high cholesterol, and 74% have arthritis. 15% are also on Medicaid. Their average risk score is 1.12, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Christopher Littmann's median patient age at 61, with 58% women.

In 2024, Christopher Littmann wrote 556 Medicare Part D claims for 213 patients. 99% of them were for generic drugs. CMS names the drug for 493 of them, across 10 drugs with 11 or more claims each, at $9,131 in total drug cost.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 81 out of 100 for Christopher Littmann for performance year 2024, reported as part of a group. Christopher Littmann accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Christopher Littmann as offering telehealth.

CMS Open Payments shows 6 general payments to Christopher Littmann from 3 drug and device companies in 2024. Food and beverage make up the largest share, 100% of the total. Medtronic, Inc. paid the most, $267.